Literature DB >> 12775762

Protection and compensation in the influenza virus-specific CD8+ T cell response.

Richard J Webby1, Samita Andreansky, John Stambas, Jerold E Rehg, Robert G Webster, Peter C Doherty, Stephen J Turner.   

Abstract

Influenza virus-specific CD8+ T cells generally recognize peptides derived from conserved, internal proteins that are not subject to antibody-mediated selection pressure. Prior exposure to any one influenza A virus (H1N1) can prime for a secondary CD8+ T cell response to a serologically different influenza A virus (H3N2). The protection afforded by this recall of established CD8+ T cell memory, although limited, is not negligible. Key characteristics of primary and secondary influenza-specific host responses are probed here with recombinant viruses expressing modified nucleoprotein (NP) and acid polymerase (PA) genes. Point mutations were introduced into the epitopes derived from the NP and PA such that they no longer bound the presenting H2Db MHC class I glycoprotein, and reassortant H1N1 and H3N2 viruses were made by reverse genetics. Conventional (C57BL/6J, H2b, and Ig+/+) and Ig-/- (muMT) mice were more susceptible to challenge with the single NP [HKx31 influenza A virus (HK)-NP] and PA (HK-PA) mutants, but unlike the Ig-/- mice, Ig+/+ mice were surprisingly resistant to the HK-NP/-PA double mutant. This virus was found to promote an enhanced IgG response resulting, perhaps, from the delayed elimination of antigen-presenting cells. Antigen persistence also could explain the increase in size of the minor KbPB1703 CD8+ T cell population in mice infected with the mutant viruses. The extent of such compensation was always partial, giving the impression that any virus-specific CD8+ T cell response operates within constrained limits. It seems that the relationship between protective humoral and cellular immunity is neither simple nor readily predicted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12775762      PMCID: PMC165859          DOI: 10.1073/pnas.1232449100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  50 in total

Review 1.  Dendritic cells as vectors for therapy.

Authors:  J Banchereau; B Schuler-Thurner; A K Palucka; G Schuler
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 2.  The role of the antibody response in influenza virus infection.

Authors:  W Gerhard
Journal:  Curr Top Microbiol Immunol       Date:  2001       Impact factor: 4.291

3.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules.

Authors:  K Falk; O Rötzschke; S Stevanović; G Jung; H G Rammensee
Journal:  Nature       Date:  1991-05-23       Impact factor: 49.962

4.  Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice.

Authors:  M J Grusby; R S Johnson; V E Papaioannou; L H Glimcher
Journal:  Science       Date:  1991-09-20       Impact factor: 47.728

5.  The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides.

Authors:  A R Townsend; J Rothbard; F M Gotch; G Bahadur; D Wraith; A J McMichael
Journal:  Cell       Date:  1986-03-28       Impact factor: 41.582

6.  Recombinant vaccinia viruses and the development of immunization strategies using influenza virus.

Authors:  P C Doherty; W Allan; D B Boyle; B E Coupar; M E Andrew
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

7.  Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells.

Authors:  W Allan; Z Tabi; A Cleary; P C Doherty
Journal:  J Immunol       Date:  1990-05-15       Impact factor: 5.422

8.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

9.  The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.

Authors:  M E Andrew; B E Coupar; D B Boyle; G L Ada
Journal:  Scand J Immunol       Date:  1987-01       Impact factor: 3.487

10.  Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

Authors:  F Berard; P Blanco; J Davoust; E M Neidhart-Berard; M Nouri-Shirazi; N Taquet; D Rimoldi; J C Cerottini; J Banchereau; A K Palucka
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307

View more
  65 in total

1.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

2.  Conserved T cell receptor usage in primary and recall responses to an immunodominant influenza virus nucleoprotein epitope.

Authors:  Katherine Kedzierska; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-22       Impact factor: 11.205

3.  Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion.

Authors:  Nicole L La Gruta; William T Rothwell; Tania Cukalac; Natasha G Swan; Sophie A Valkenburg; Katherine Kedzierska; Paul G Thomas; Peter C Doherty; Stephen J Turner
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

4.  A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies.

Authors:  Nicole L La Gruta; Katherine Kedzierska; Ken Pang; Richard Webby; Miles Davenport; Weisan Chen; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

5.  Repeated influenza vaccination of healthy children and adults: borrow now, pay later?

Authors:  F Carrat; A Lavenu; S Cauchemez; S Deleger
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

6.  Preexisting antibody response against 2009 pandemic influenza H1N1 viruses in the Taiwanese population.

Authors:  Chia-Yu Chi; Ching-Chuan Liu; Chia-Chun Lin; Hsuan-Chen Wang; Yung-Tsung Cheng; Chung-Ming Chang; Jen-Ren Wang
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

7.  A simple mathematical model helps to explain the immunodominance of CD8 T cells in influenza A virus infections.

Authors:  Andreas Handel; Rustom Antia
Journal:  J Virol       Date:  2008-06-11       Impact factor: 5.103

8.  Stimulation of protective and cross-protective immunity against influenza B virus after adjuvant mucosal immunization of mice.

Authors:  L Prokesová; P Zanvit; M Havlícková; J Tácner; M Jirkovská; P Petrásková; O Novotná; D Cechová; J Julák
Journal:  Folia Microbiol (Praha)       Date:  2010-02-07       Impact factor: 2.099

9.  Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition.

Authors:  Alex Theodossis; Carole Guillonneau; Andrew Welland; Lauren K Ely; Craig S Clements; Nicholas A Williamson; Andrew I Webb; Jacqueline A Wilce; Roger J Mulder; Michelle A Dunstone; Peter C Doherty; James McCluskey; Anthony W Purcell; Stephen J Turner; Jamie Rossjohn
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

10.  Splenic priming of virus-specific CD8 T cells following influenza virus infection.

Authors:  Damian L Turner; Kara L Bickham; Donna L Farber; Leo Lefrançois
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.